On the recordAugust 3, 2009
To me, that choice is clear. We need safe products and we need innovation, and the best way to achieve both goals is not through litigation created by this bill, but through a strong, well-funded FDA.
Source
congress.govEditor's note · Context
Harkin advocates for FDA oversight over litigation for medical device safety.
Share & report
More from Tom Harkin
Nov 13, 2014
I would like to recognize the outstanding career of a dedicated civil servant, Iowan Dr. Nancy Cox, who will retire in November 2014 after 37 years of distinguished Federal service at the U.S. Centers for Disease Control and Prevention…
Nov 20, 2014
Mr. Presidet, this morning we convened a hearing to consider the President's nomination of Lauren McFerran to fill an impending vacancy on the National Labor Relations Board. Ms. McFerran is well known to most of us as a senior staffer on…
Dec 10, 2014
Mr. President, in 1997, Beth Stein, a talented young woman armed with a razor-sharp mind and relentless attention to detail, arrived on Capitol Hill as counsel to a true American hero, U.S. Senator John Glenn. As his investigative counsel…
Dec 8, 2014
Mr. President, I speak in support of the nomination of Lauren McFerran to fill an approaching vacancy on the National Labor Relations Board. I was heartened by the recent cloture vote in support of the McFerran nomination and urge my…
Other voices in this conversation
